- ICH GCP
- US Clinical Trials Registry
- Clinical Trial NCT04506944
The Epidemiology of Rickettsial Infections in South India: Cohort Study
The Epidemiology Of Scrub Typhus And Rickettsial Infections In A Highly Endemic Rural Setting In South India: Population-Based Cohort Study
There is enough evidence to suggest that scrub typhus and spotted fever group rickettsioses are common causes of febrile illness in India. Serological evidence also exists for murine typhus, but is rarely tested for. Incidence, risk factors, clinical features and molecular epidemiology of these three infections are poorly understood. Delays in disease recognition and treatment may cause thousands of preventable deaths across India.
The objectives of the research are to determine the incidence and risk factors of scrub typhus, spotted fever and murine typhus by severity, to determine clinical features of these neglected and often unrecognized infections. Further to study the effect of previous infection on incidence and severity of subsequent infections. Finally to study the association between vector parameters and scrub typhus risk.
Enrolled will be 30,000 individuals who will be followed up for the development of fever using active and passive surveillance. Active surveillance will include household screening every 3-6 weeks. Fever cases occuring in the past two months will be tested for Scrub typhus, murine typhus and spotted fever IgG/IgM. 4000 individuals will be followed up by annual serological testing to identify asymptomatic infections. Participants notifying the study team with ongoing fever will undergo blood testing for acute diagnosis of rickettsial infection (IgM, PCR). In addition, we will enroll fever cases at study clinics who are not part of the main cohort. The research includes spatial and socio-economic risk factor analysis. Rodents carrying mite larvae will be trapped to compare the intensity of mite infestation between areas of high and low risk for human scrub typhus.
The data on incidence, burden of disease and environmental determinants of scrub typhus, spotted fever and murine typhus will be used for health care planning and information campaigns for the public and medical professionals.
Study Overview
Status
Conditions
Intervention / Treatment
Detailed Description
The aim of the cohort study is to better understand the epidemiology, sero-epidemiology and transmission of scrub typhus, murine typhus and tick-borne spotted fever. The overall focus of the work will be on scrub typhus, being the most important of the three from the public health perspective. We aim to determine the "severity pyramid" of serological, symptomatic and severe infection. The results from this study will help clinicians to understand the natural course of scrub typhus infection, health policy makers to estimate the global burden and the scope for community-based interventions, and immunologists to better understand the immunogenicity of single and repeat infections.
The specific objectives are to:
- Estimate the incidence of symptomatic and severe scrub typhus infection in the community.
- Estimate the incidence of serological (asymptomatic) scrub typhus infection.
- Estimate the effect of previous scrub typhus infection (sero-positive at baseline) on the risk of subsequent infection and disease severity (subclinical vs clinically apparent). This includes the effect of antibodies in mothers on the risk of severe infection in young children via residual maternal antibodies.
- Estimate the effect of potential risk factors such as age, gender, occupation, water/sanitation access and comorbidity on the risk of scrub typhus infection.
- Estimate the effect of spatial-temporal risk factors for scrub typhus by identifying high risk areas, accounting for human population density and land use.
- Compare the rate of rodent trappings and vector parameters of chiggers between high risk and low risk areas identified under 5).
- Estimate the disease burden associated with scrub typhus and the economic impact of scrub typhus in terms of loss of earnings and health expenditure.
- Estimate the incidence of asymptomatic and symptomatic murine typhus and spotted fever infection and explore associated socio-demographic, spatial and vector-related risk factors.
STUDY OVERVIEW
The study will be a population-based cohort study over two years (i.e. two scrub typhus seasons) in about 30,000 people living in approximately 40 villages with a sero-prevalence of at least 15% (see flow diagram above). These individuals will be followed-up through active surveillance for recent febrile illnesses (clinical cohort). For passive surveillance, participants will be encouraged to notify the study team in case of fever or come to one of 4 local study clinics. At study clinics we will also enrol fever cases who are not part of the clinical cohort, i.e. have not been enrolled prior to their fever. The study will include a smaller cohort (sero-cohort) for serological surveillance of 4000 people drawn from the 30,000 people of the clinical cohort. Longitudinal serological surveys linked to active surveillance are essential to estimate true attack rates unbiased by disease severity. The sero-cohort will consist of three annual blood testing in the same group of participants over two scrub typhus seasons (baseline, inter-season, endline).
Target population- A pilot study showed that scrub typhus infection is highly focal This makes it difficult to define a target population for the purpose of making inferences. We will define the target population in terms of the village level sero-prevalence. The aim is to correlate the incidence of scrub typhus with the sero-prevalence at village level. This will allow using the results of the study to predict the expected incidence and burden of scrub typhus in other settings with a known sero-prevalence, and eventually estimate the global burden of scrub typhus (not part of the study but a potential extension of the work). The target population for the study is therefore "villages in which the IgG sero-prevalence is at least 15%".
Study Type
Enrollment (Actual)
Contacts and Locations
Study Locations
-
-
Tamil Nadu
-
Vellore, Tamil Nadu, India, 632004
- Christian medical college
-
-
Participation Criteria
Eligibility Criteria
Ages Eligible for Study
- Child
- Adult
- Older Adult
Accepts Healthy Volunteers
Sampling Method
Study Population
General population cohort: all residents in scrub typhus endemic villages Serological cohort: random sample of 4000 individuals older than 10 years present at the time of the initial baseline survey visit
hospital case cohort: cases of all ages attending study clinics for undifferentiated fever of at least 5 days duration
Description
Inclusion Criteria:
- General population cohort: residing in study villages
- serological cohort: aged 10 years or older
- Hospital cohort: all ages
Exclusion Criteria:
- None
Study Plan
How is the study designed?
Design Details
Cohorts and Interventions
Group / Cohort |
Intervention / Treatment |
---|---|
General population
Whole population of scrub typhus endemic villages
|
No specific exposure is explored.
|
hospital case population
cases recruited at study clinics who are not enrolled in general population cohort
|
No specific exposure is explored.
|
Serological cohort
random subset of 4000 participants above the age of 10 drawn from general population cohort
|
No specific exposure is explored.
|
What is the study measuring?
Primary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
---|---|---|
Incidence of scrub typhus
Time Frame: 2 years
|
clinically apparent infection
|
2 years
|
Incidence of spotted fever
Time Frame: 2 years
|
clinically apparent infection
|
2 years
|
Incidence of murine typhus
Time Frame: 2 years
|
clinically apparent infection
|
2 years
|
Secondary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
---|---|---|
Incidence of serological infection (scrub typhus)
Time Frame: 2 years
|
measured using paired samples from sero-cohort
|
2 years
|
Incidence of serological infection (spotted fever)
Time Frame: 2 years
|
measured using paired samples from sero-cohort
|
2 years
|
Incidence of serological infection (murine typhus)
Time Frame: 2 years
|
measured using paired samples from sero-cohort
|
2 years
|
Incidence of complicated infection (scrub typhus)
Time Frame: 2 years
|
based on pre-defined complications: ARDS, shock, CNS, renal failure, myocarditis
|
2 years
|
Incidence of complicated infection (spotted fever)
Time Frame: 2 years
|
based on pre-defined complications: ARDS, shock, CNS, renal failure, myocarditis
|
2 years
|
Incidence of complicated infection (murine typhus)
Time Frame: 2 years
|
based on pre-defined complications: ARDS, shock, CNS, renal failure, myocarditis
|
2 years
|
Collaborators and Investigators
Collaborators
Investigators
- Principal Investigator: Wolf-Peter Schmidt, PhD, LSHTM
- Study Chair: Daniel Chandramohan, PhD, LSHTM
Study record dates
Study Major Dates
Study Start (Actual)
Primary Completion (Actual)
Study Completion (Actual)
Study Registration Dates
First Submitted
First Submitted That Met QC Criteria
First Posted (Actual)
Study Record Updates
Last Update Posted (Actual)
Last Update Submitted That Met QC Criteria
Last Verified
More Information
Terms related to this study
Additional Relevant MeSH Terms
Other Study ID Numbers
- MRC typhus cohort 1
Plan for Individual participant data (IPD)
Plan to Share Individual Participant Data (IPD)?
IPD Plan Description
IPD Sharing Time Frame
IPD Sharing Access Criteria
IPD Sharing Supporting Information Type
- STUDY_PROTOCOL
- ICF
- ANALYTIC_CODE
Drug and device information, study documents
Studies a U.S. FDA-regulated drug product
Studies a U.S. FDA-regulated device product
This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.
Clinical Trials on Scrub Typhus
-
University of OxfordMahidol Oxford Tropical Medicine Research Unit; Centre National de la Recherche... and other collaboratorsCompleted
-
Myanmar Oxford Clinical Research UnitUniversity of Oxford; Swiss Tropical & Public Health Institute; Medical Action... and other collaboratorsCompleted
-
University of OxfordChiangrai Prachanukroh HospitalCompleted
-
Dong-Min KimCompletedScrub TyphusKorea, Republic of
-
University of OxfordShoklo Malaria Research Unit; Chiangrai Prachanukroh HospitalRecruiting
-
Dong-Min KimCompletedScrub TyphusKorea, Republic of
-
University of OxfordMahidol University; Li Ka Shing Foundation; Chiangrai Prachanukroh HospitalCompleted
-
Eulji University HospitalChungnam National University Hospital; Chungbuk National University HospitalCompletedCardiovascular Complication | Scrub TyphusKorea, Republic of
Clinical Trials on No intervention
-
Wave NeuroscienceCompletedAutistic DisorderUnited States
-
University of Alabama at BirminghamCompletedInflammatory Bowel Diseases | Colorectal Cancer | Diverticular Diseases | Social BehaviorUnited States
-
Janssen Research & Development, LLCCompletedLupus Erythematosus, Systemic | Lupus Erythematosus, Cutaneous | Lupus Erythematosus, DiscoidUnited States, Poland
-
Hospital Universitario La Paz3MVX CCB and Agaplesion Markus Krankenhaus, Frankfurt a.M., Germany.; Department...RecruitingEmbolism | Atrial Fibrillation | Arrhythmia | Stroke, Acute | Stroke Sequelae | AblationSpain
-
Southern California College of Optometry at Marshall...Ohio State University; University of Houston; Alcon Research; University of Waterloo and other collaboratorsCompletedContact Lens Complication | Contact Lens Acute Red Eye | Contact Lens Related Corneal Infiltrate (Disorder) | Contact Lens-Induced Corneal Fluorescein StainingUnited States, Canada
-
University of Dublin, Trinity CollegeCompleted
-
Hôpital Necker-Enfants MaladesUnknown
-
China Medical University HospitalUnknownIntention to Stay, Turnover Behavior
-
University of PittsburghCompletedChronic Low Back PainUnited States